Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sen Sun, Lu Liu, Hongming Song & Hong Li. (2022) Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats. Pharmaceutical Biology 60:1, pages 1944-1948.
Read now
Read now
Fagen Li, Ke Cao, Maoyun Wang, Yi Liu & Yin Zhang. (2022) Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway. Bioengineered 13:4, pages 10112-10123.
Read now
Read now
Articles from other publishers (12)
Ling Shen, Yuancheng Li, Guiying Hu, Xinli Song, Xiaoshuang Wang, Xiaoqi Li & Xiaoyuan Xu. (2023) Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling. Functional & Integrative Genomics 23:2.
Crossref
Crossref
Chenchen Liu, Huiling Chen, Yida Zhang, Meng Li, Qiyao Jiang, Zhendong Wang, Liangwen Yu, Qi Wang, Huafeng Pan & Yue Zhuo. (2023) Combination of chemical profiling and network pharmacology analysis to investigate the potential mechanism of Li‐Zhong‐Xiao‐Pi granules in the treatment of gastric precancerous lesions. Biomedical Chromatography 37:4.
Crossref
Crossref
Dongqin Xia, Wenjie Li, Ce Tang & Juan Jiang. (2023) Astragaloside IV, as a potential anticancer agent. Frontiers in Pharmacology 14.
Crossref
Crossref
Liangxing Zhou, Mengpeng Li, Zhengbin Chai, Junli Zhang, Kuan Cao, Lei Deng, Yanming Liu, Cun Jiao, Gang-Ming Zou, Jibiao Wu & Fabin Han. (2022) Anticancer effects and mechanisms of astragaloside‑IV (Review). Oncology Reports 49:1.
Crossref
Crossref
Qian Shen, JunChen Li, Xue Pan, ChuanLong Zhang, XiaoChen Jiang, Yi Li, Yan Chen & Bo Pang. (2022) An immune-related microRNA signature prognostic model for pancreatic carcinoma and association with immune microenvironment. Scientific Reports 12:1.
Crossref
Crossref
Jingwei Ma, Meng Zhu, Xiaofeng Ye, Bo Wu, Tao Wang, Muyuan Ma, Tao Li & Ning Zhang. (2022) Prognostic microRNAs associated with phosphoserine aminotransferase 1 in gastric cancer as markers of bone metastasis. Frontiers in Genetics 13.
Crossref
Crossref
Yu Zhang, Kun Zhuang, Shanshan Yuan, Wangli Si, Yijun Li, Jun Zhang & Jiaming Liu. (2022) Effects of mir-195 Targeted Regulation of JAK2 on Proliferation, Invasion, and Apoptosis of Gastric Cancer Cells. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Crossref
Xujun You, Yongrong Wu, Qixin Li, Wen Sheng, Qing Zhou & Wei Fu. (2022) Astragalus–Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy. Frontiers in Pharmacology 13.
Crossref
Crossref
William Frank Ferris. (2022) The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract. Frontiers in Oncology 12.
Crossref
Crossref
Qi Xu, Jia-Lin Xu, Wen-Quan Chen, Wen-Xiu Xu, Yu-Xin Song, Wen-Juan Tang, Di Xu, Meng-Ping Jiang & Jinhai Tang. (2022) Roles and mechanisms of miR-195–5p in human solid cancers. Biomedicine & Pharmacotherapy 150, pages 112885.
Crossref
Crossref
Haiyan Wang, Hanqing Lin, Tao Zhang & Haiying Jia. (2022) Matrine Intensifies the Sensitivity of Cisplatin in NPC Cells via mTOR-Mediated Autophagy. International Journal of Pharmacology 18:3, pages 388-397.
Crossref
Crossref
Zixuan Wu, Xiyang Pan, Chaosheng Deng, Minjie Cai, Kai Yuan, Peidong Huang & Guoqi Shi. (2022) Mechanism of Herb Pairs Astragalus mongholicus and Curcuma phaeocaulis Valeton in Treating Gastric Carcinoma: A Network Pharmacology Combines with Differential Analysis and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-18.
Crossref
Crossref